Buy Aurobindo Pharma: Deepak Mohoni

ET Now spoke to Deepak Mohoni, Director, trendwatchindia.com, on his views on Aurobindo Pharma.

What is the call on Aurobindo Pharma?

It has been rising at a fairly steady rate of about 8% to 10% a week for nearly a month and it is a very straight line if you look at the chart.

This is very much a bull market stock. If there is a bull market, Aurobindo quite comfortably outperforms most of the other pharma stocks. The flip side of this is if there is a bear market, it does give back a lot of these gains. So the outlook is beginning to look a little bullish, not a confirm bull market but a lot of things you associate with the bull market are beginning to happen.

So this could be worth a little bit of a punt, not huge investment thing but you buy it now and if all goes well and the index is past 5700, this should give very good returns over the next 3-4 months.